Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Eltrombopag | 496775-61-2 | MFCD20926253 | C25H22N4O4 | 200 MG
Supplier: Medchemexpress LLC HY15306200MG
Eltrombopag is an orally active thrombopoietin receptor nonpeptide agonist. It exhibits thrombopoietic activity and has been studied for low blood platelet counts in chronic immune thrombocytopenia. It is also used in cardiovascular research, shows strong inhibitory effects against multidrug-resistant Staphylococcus aureus, and can induce apoptosis in hepatocellular carcinoma (HCC).
- Exhibits thrombopoietic activity
- Used in research for low blood platelet counts in chronic immune thrombocytopenia
- Utilized in cardiovascular research
- Shows strong inhibitory effects against multidrug-resistant Staphylococcus aureus
- Can induce apoptosis in hepatocellular carcinoma (HCC)
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?